Minerva Neurosciences Inc (NASDAQ:NERV)

7.20
Delayed Data
As of Apr 20
 +0.05 / +0.70%
Today’s Change
4.80
Today|||52-Week Range
11.15
+19.01%
Year-to-Date
No recent news for Minerva Neurosciences Inc.

Today’s Trading

Previous close7.15
Today’s open7.05
Day’s range6.90 - 7.35
Volume98,964
Average volume (3 months)186,114
Market cap$222.5M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+14.66%
Earnings growth (this year)-24.75%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...+0.17+1.57%
NBRVNabriva Therapeutics...+0.18+3.56%
PETXAratana Therapeutics...+0.11+2.21%
ARDXArdelyx Inc-0.05-1.02%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$31.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Rémy Luthringer
President
Richard Russell
Corporate headquarters
Waltham, Massachusetts

Forecasts